Clinical trial Recruiting at 1 site Observational

Examining brain activity during complex walking in people with atypical Parkinsonian syndromes

Official title: Walking and Thinking - Brain Activity During Complex Walking in Atypical Parkinsonian Syndromes

Run by Karolinska Institutet · NCT06906276 · Data updated 2026-11-12

This study looks at how brain activity changes when people with atypical Parkinsonian syndromes, like PSP and MSA, try to walk in different ways to help improve their independence.

Quick facts

Study typeObservational
SexAll
Enrollment30 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations1 site (Solna, Solna)
StatusRecruiting
StartedMarch 14, 2025
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedOctober 22, 2026
Trial IDNCT06906276 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with Progressive Supranuclear Palsy or Multiple System Atrophy who can walk for up to 5 minutes.

Probably not a fit

Patients with severe cognitive difficulties, freezing of gait, or other neurological diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates how brain function is affected during complex walking tasks in individuals diagnosed with atypical Parkinsonian syndromes, such as Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA). Using functional Near-Infrared Spectroscopy (fNIRS), the study aims to assess brain activity alongside behavioral evaluations of motor and cognitive performance during various walking conditions. The goal is to better understand the motor-cognitive interactions that are crucial for maintaining an independent lifestyle in this population, which may inform future rehabilitation strategies.

Why it matters

Potential benefit: If successful, this study could lead to improved rehabilitation strategies that enhance motor-cognitive performance in patients with atypical Parkinsonian syndromes.

How similar studies have gone: While the specific approach of using fNIRS in this context may be novel, studies on motor-cognitive interactions in similar populations have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* clinical diagnosis of PSP according to Movement Disorder Society (MDS) (2017) or
* MSA according to MDS criteria (2022)
* the ability to walk with or without a mobility device for ≤5 minutes continuously

Exclusion Criteria:

* cognitive difficulties affecting the ability to understand and/or follow verbal/written - instructions
* severe freezing of gait
* Severe hearing or visual impairments that affect participation in the assessments
* Other neurological diseases
* Other diseases that can affect gait or balance.

Where it's running

  • Karolinska Institutet
    Solna, Solna, Sweden
    Recruiting

Study contacts

  • Principal investigator: Franziska Albrecht, PhD — Karolinska Institutet
  • Study coordinator: Compliance Office Karolinska Insitutet
  • Email: compliance@ki.se
  • Phone: +46852480000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.